12-0-T e trade canoylphorbol a cetate (TP A) applied to mouse e ars rapidly induces an edema which is maximal by 6 hr but has subs tantially wane d by 24 hr. (This is in contrast to many inflammatory agents that cau s e a prolonged e d e ma lasting many days.) Reapplication of TP A at 16-24 hr will not provoke a s econd e d e matous res ponse although increas ed erythema is evident. Arachidon ic a cid (AA) applied to mous e e ars (4 mg) provoke s a n even more rapid edema which is maximal at 1 hr and has s ubstantially waned by 6 hr. R eapplication of AA at 3-24 hr also will not provoke a second e d e matous res ponse although, again, incre ased erythe ma does result. Pre tre atment of ears with AA r esults in inhibition of the ed ema r esponse to s ubsequent application of TPA, and TPA pretreatment moderately inhibits a s ubsequent r esponse to AA. T P A-induce d e dema can b e d elaye d by agents such a s naproxen, an inhibit or of AA cyclooxygenase. In co'ntras t, AA-induce d e d ema is inhibited only by a gents , s u ch as phenidone , that inhibit both cyclooxygenase and lipoxygenase . The data s uggest that the e d emas r esult from inte r a ction of the products of the cyclooxygenase a nd lipox ygenase pathways of AA m et a bolism. The la ck of secondary e dema r esponse appears to b e related to the ina bility of TP A or AA to reinduce vascular p ermeability. The effe ct is sp ecific to AA and TP A; r esponses to xylen e or anthralin are unaffe cted by TPA or AA pre tre atment. It is postulated that the tachyphyla ctic e ffects observe d involve lipox ygenase m etabolite s of AA, In t h e search for novel th e ra pe ut ic age n ts useful in th e topi cal t reatm ent of infla mmato ry skin condit io ns, consid er a ble e mph asis must be p laced on t h e rou t ine scr eening of compounds in a nimal m od els . With respect to known classes of a ge nts su ch as to pical corticosteroids whose m ech a nism of action is fa irly well understood [1] a nd whose clinical effi cacy is virt u all y guara nteed , a ny a nimal m odel y ielding r elative pote ncy estimates serves well [2], alt h ough occasio nal pitfalls ar e en counte red [3] . U nd er t his circums ta nce we ar e no t normall y concerned wit h t h e mecha nisms involved in the m odel infla mmat ion , nor even with t h e r eleva nce of t h e model to huma n skin infla mmation . H owever, wi t h respect to no vel agents, whose efficacy a nd m echa nism of action a re unkn own , t h e r eleva n ce a nd proper t ies of t h e a nima l mod el must be give n due cons ideration so t hat false-posit ive or negative resul ts d o no t lead us too fa r astr ay.
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One of the m ore commo nl y used a nima l m od els is that of 
Abb reviations:
AA: arac hidonic ac id T P A: 12-0-tetradeca noylphorbol acetate r od en t ear ede m a induced by a pplication of cro t on oil [2] or its active constit ue nt 12-0-tetr a d ecanoylphorbol acetate [4] . T his latter co mpo und, TP A, is unde r active investigatio n as a t umor prom oter , as a n indu cer of epiderma l hy perplasia, a nd as an effec t or or ac tuator in a mult it ude of in vi tro syste m s . The processes involved in t h e induction of inHa mmation by topi cal a pplication of t his compound ar e no t well unde rstood , al t h ough t h e M erck group [5] h as a m assed considera ble evide nce t h at elevated levels o f t h e hy droperoxy e nd oper oxid e, PGG2, form ed from arachido ni c acid (AA) , a re associ.ated with edem a induction.
Our own inte rest in t he m ech a nism s involved in TPA-indu ced infla mmation was stimulated by th e a bove consider atio ns, as well as th e observa tion t h at TP A-induced ear ed em a was s h or tli ved in comparison wi t h th at induced by oth er phlogistic age n ts such as r etinoic acid , oxazol one, and a nthra lin. While T P Ainduced edem a could be prolonged by using high er d oses, reapplication of the usua l dose of 1 Ilg/ ear , a fte r a 24-hr in te rval, did not r esul t in r eindu ction of ed em a. W e repor t h ere our studies on a phe nome non which we interpret as a s pecific tac hyphylaxis to inductio n of vascular leakage which m ay involve products of AA m e ta bolis m .
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MATERIALS AND METHODS
Anim als
Female Swiss Webster mice, 5-8 weeks old, were obtained from Simonse n Labs, Gilroy, Ca liforni a and held under standru'd conditions for 1 wee k prior to use, wi th foo d and water ad lib. Animals were rand oml y assigned to treatment groups of 8, housed together in a cage.
Ch emica.ls
12-0-T etradecanoyl phorbol acetate was fr om Chemi cal Ca rcinoge ns, Eden Prairie, Minnesota; anthralin (US P, > 95%) from City Chemical Corp., New York, New Yo rk; all-tra ns-retinoic ac id, ru'achid onic ac id, and oxazolone from Sigma Chemical Co., SL. Louis, Misso uri. Co mpounds we re prepared as solu tio ns in reagent-grade acetone just prior to application.
Trea.lmenls
T est materi als dissolved in aceto ne we re de li vered to the right ears only of mi ce by means of an auto matic microliter pipet. Volumes of 10 II I were delivered to each of the inner and outer surfaces of the ear. This volume spread eve nly over the wh ole surface of the ear with minimal drainage to the base and onto the skull and nec k.
Edem a M easurements
For ear thi ckness determinations, an Oditest dial caliper ga uge, 0-0.8 inches, wi th gradations of 0.001 inches modified to increase the co ntact surface ru'ea and redu ce the tension, was applied to the tip of the eru·. Ear 'thickn ess was recorded in uni ts orO.OOl inches. In ord er to minimize va riation du e to technique, measurements throughout an ex periment were performed by a single investigato r. This method allows edema development in individual animals to be followed tl1l'ough time wi thout the need for anesthesia. In ord er to provide a more objective assessment of edema at critical time poin ts, appropriate experiments were repeated in which groups of animals were kill ed by cervical dislocation, the ears immediately removed wi th sharp scissors, and 8 mm diameter plugs were obtained from the tip with a biopsy punch. The plugs were immediately we ighed to the nearest 0.1 mg. In both cases, the means ± standard devi ation were calcul ated for each treatment group (N = 8).
Histologic Pmcedures
At app ropriate in terva ls after application of the inf1a mmatory agents, ear s from groups of 4 mi ce were re mov ed , f'ix ed in neutra l buffered forma lin, paraffin embedded a nd sectioned at 7 /l m. S lid es were tained wit,h hema toxylin -eos in or wit h Wright's buffered differe nt ia l s ta in .
HESULTS
Comparative Time Course of TPA-Induced Ear Edem a
When 1 !J.g TP A is applied to t he ears of mice, vasodilatation beco mes a pparent by 1.5 nr, a nd ede ma max imizes at 6 hI', waning t h ereafter to nea r contro l levels at 24 hI' (Fig 1) . Alt hough t he edema has substantially resolved at 24 hI', t he ea rs are still visibly vasodil ated and hyperemic, as shown prev iously by H ecker et al [6] . Inflamm atory cells are still present at 24 a nd 48 hr ( Table I) . T his ra pid r esolu tion of edema in the TPA-
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HOURS AFTER APPLICATION
F IG l. Time l:o urse of mouse ea r edema res ponse to topica lly a pplied agen ts. Th e agent.s we re a pplied in 20 /ll aceto ne at doses of: TPA, J /lg (e); oxazolone, 1 mg (0 ); a n th ra lin, 200 /lg (0), a nd retinoic acid, 200 /lg (.6.) . Th e oxazolone response was obtained in a nim a ls sens it ized by prior topical a pplication to abdo min a l s kin. inflamed ear is dose depende nt since a pplication of 10 {lg/ ear results in a mu ch prolo nged response a nd event ual necrosis. Doses lower t ha n 1 !J.g produ ced consistently less ed em a, with the t hreshold of detecta ble edema OCCUlTing at 0.1 !J.g. This is in contrast to the much lower doses that produce erythema but no edema [6] . Conseq uently, unless oth erwise stated, all applications of TPA were made at t he 1 !J.g/ ear level.
In contrast to t he inflammatory reactions produced by a nt hralin, retinoic acid, or oxazolo ne in sensitized a nimals (Fig 1) t he response to TPA a ppear ed to be pecul iarly s hor t-lived, at least wi t h respect to edema.
Ta. chyphylaxis to R epeat Applications of TPA
In view of the short-li ved ede ma r esponse to a single ap plication of TP A, several attempts were made to boost or pro long th e response by reapplying TPA between 16 a nd 24 h1'. Alt hough ears t reated with TPA 24 hr previously (Fig 2) sh owed residua l edema a nd erythem a, reapplication of TPA resulted in increased vasod ilatation and erythe ma bu t substantially less edema tha n anticipated. T his tachyphylax is appeared to be specific to TPA since application of th e unrelated agents, a nthralin (Fig 2) or xyle ne (not s hown) , resul ted in return of maximal edema.
The tachyphylactic response to TPA was exa min ed wi t h respect to dose a nd time as s hown in Fig 3. Ears were initially treated wi t h eit her the optimal dose (1 !J.g) or t he t hreshold dose (0.1 !J.g) of TPA and t hen t reated with 1 !J.g TPA at 24 hI' (Fig 3A ) . Animals initially receiving t h e t hreshold dose responsed maximally to t he second dose; a nimals ini tially receiving t he optimal dose of TPA responded minimally . In a series of experiments using initial doses of 0.1-2 !J.g TPA, t he edem a response to 1 flg TPA at 24 h I' was inversely proportio nal to t h e a mount of edema prod uced by the fir ~ dose.
If t he second a pplication of TP A was delayed until 48 hI' (Fig  3B) , m aximal edema, not tachyphylaxis, was observed. When ears we re treated seq uentiall y with TPA at 0,24, a nd 48 hI' (Fig  3C ) , maximal edem a was produced after t he t hird dose in spite of t he fa ct t hat t hese sam e a nima ls had failed to respond to t he second dose at 24 hI'. 
Arachidonic Acid-Induced Ew: Edema
In order to explore the role of AA release and m etabolism in TPA-induced edema and subsequent tachyphylaxis, the effects of topical a pplication of prostagla ndins a nd AA on the mouse ear were examined. At doses of 10-40 p.g/ear, PGE , and PGE2 caused marked vasod ilatation within 30 min, but the ears did not become edem atous; PGF2" had no observable effect. Pretreatment of ears with these prostagla ndins did not alter the inf1ammatory reaction produced by TP A.
When AA was applied at 40 p.g/ear, a n intense vasodilatation a nd e rythema were observed within 5 min, but again no ede ma Vol. 80, No.1 developed (Fig 4) . However , when the a pplied dose was increased to 0.4 mg and 4 mg, a threshold and maximal edem a, respectively, were produced (Fig 4) . The nota ble feature of AAinduced edema was the rapidity of onset and the even more rapid waning compared with TP A. Because of the high dose of AA used , it was necessary to demonstrate that nonspecific toxic effects were minimal . The resu lts of histologic studies compa ring AA-with TPA-induced inflammation are give n in T able 1. One hour after AA application, ear sections showed vasodilatation, derm a l edema, and masses of polymorphonuclear and large mononuclear cells, not only in blood vessels, bu t alread y in the dermal interstitium. By 3 hr the number of inf1a mmatory cells appeared to be decreased although this could not be quantitated because of the reduction in edema. At 6 hI', t h e reduction in ede ma and cellular infiltrate wer e o bvious. During this period no epidermal changes suggestive of necrosis were detected . By 24 and 48 hI', it was difficult to find a ny inf1a mmatory cells; epidermal mitoses were frequent, but by comparison with TPA-treated ears there was little, if a ny, epidermal hyperplasia. By comparison , oleic acid at 20 m g/ear produced a slight ear reddening, but no significant edem a over a 48-h1' observation period .
Arachidonic Acid-Induced Tachyphy laxis
Since AA a ppeared to mimic the infla mmatory effe cts of TPA, but with an accelerated time course, t h e effect of AA pretreatment on TPA-induced edema was examined. When AA (4 mg/ear) was applied 2 h1' prior to TPA (Fig 5A) , the response to the latter was moderately but significantly diminis hed . If the time between AA a nd TPA treatments was extended to 20 11.1' (Fig 5C) , suppression of TPA-induced ede ma was virtua lly complete. As shown in the previous experiments (Fig 3A) , the degree of tachyphylaxis induced by AA is depende nt on the dose used initially. Wh en ears were pretr eated with a suboptimal dose of AA (1 mg/ear) , only partial inhibition of TPAinduced edema OCCUlTed (Fig 5C) .
Arachidonic acid was found to be very effective in causing tachyphylaxis to itself. In a series of time course experiments, unrespo nsiveness to a second a pplication of AA could be demonstrated over the inte rval of 2-30 hI'. Figure 6 illustrates the complete suppression of AA-induced edema 24 hI' after the initial application. At this time, the AA-pretreated ears show a slight r esidua l erythema a nd they become intensely erythem a- to us in response to th e second AA a pplication. Aga in, th e effect is fail'l y specific since both xylene a nd a ntl11'alin ar e cap able of inducing edema in AA -pretreated ears.
In order to determine whether t he tachyphyla xis was a local or system ic effect, a series of experiments was performed in which mice received an init ia l dose of AA on eit her t he left or t he right eal'. At intervals between 2 and 24 hI', all gr oups including appro pria te acetone controls were dosed a second time on th e right ear s only. In every case, t he effe ct was observed to be entirely local; pre treatme nt of t he right ear had no effect on th e subsequent response of the left ear.
Effect ofTPA Pretreatm ent on AA-Induced Edema
In a seri es of experiments in which TPA-pretreated ears were dosed wit h AA 16-24 hr la ter, there was a consistent and significant depression of t he expected AA response, bu t t he
appropriate control groups should be. If acetone-and TPA-pretreated ears are compa red for t heir response to AA, significa nt tachyphylaxis a mount ing to abo ut 30% was observed in only 2 out of 3 ex pe riments a nd inhi bition was restricted to m easw-e ments made 30 a nd 60 min after AA a pplication. The r esul ts could be in terpreted as a delay a nd t hen prolonged response to AA in TPA-pretreated a nima ls. However, if comparisons were m ade to a nima l groups which wer e TP A pretreated a nd t hen acetone dosed, thLls taking in to account t he residua l TPA-indu ced edema, TPA pretr eatme nt ap peared to produce a 40-60% reduction in t he subseq uent response to AA over observation periods of LIp to 6 lu·.
E ffect of Nonsteroidal Antiinflammatory Agents on TPAand AA-Induced Edema
S ince t he a bove r esul ts suggested t hat AA r elease a nd subsequent metabolism were important in t he observed phenomena a nd since it had been s how n th at TPA-induced edema could be prevented by no nsteroidal a ntiinflammatory agen ts [4, 7, 8] , we examined several agents for t heir effects on both TPA-a nd AA-induced edem a. While we have not confirmed the specificity of action in th e mouse ear , t h e agents were chosen based on li ter ature reports of relative inhibitory activity against arachidonate cyclooxygenase a nd lipoxygenase. N aproxen and indomethacin are relatively specific inhibitors of cyclooxyge nase [9] alt h ough inhibition of peroxidase [10] ha recently been reported. In contrast, nordihyd}'ogu aiar etic acid [11] and phenidone [9] inhibit both cyclooxygenase a nd lipoxyge nase, wi th sligh t specificity fo r t h e latter. These relative specificities have been confirm ed at least for mouse epid ermal homogenates [12] .
As can be seen in T a ble II, TPA-induced edem a is s ignificantly inhibited by all 4 agents, although t he degr ee of inhibition is dependent on th e time of m easurem en t. Thus, for exampl e, naproxen delays th e onset of m aximal edem a, bu t under t he conditions described this apparent inhibition disappears with time. It should be noted that these inhibi tory effects are observed only if t h e compounds are a pplied within 30 min before or after TP A. While a n exha ustive pharmacologic a nal- ysis of the TP A inflammation is beyond t he scope of this paper, the resul ts are consistent with a major role for AA metabolites in the production of edema. Neither naproxen nor indomethacin were consiste ntly active in the AA-induced ede ma, although t he vasodi la tation a nd erythema at 15 min were partially suppressed. S ignificant inhibition of AA-induced edema could be achieved only with agents that possessed both cyclooxygenase a nd lipoxygenase inhibi tory activity, as exemplified by phenidone a nd nordihydroguaiare tic acid .
DISCUSSION
The rapid resolution of TPA-induced ear edema in comparison with othe r mod el inflammations s timulated our investigation of t he possibl e mechanisms involved . The demonstration of a spec ific unresponsiveness with respect to ede ma indu ction suggested either a depl etion of inflammatory mediators or a tachyphy laxis to such mediators. On the basis of the following co nside rations it appeared t hat AA meta bolites might be involved in edema indu ction by TPA as well as the subsequent resoluti on a nd unresponsiveness: (1) For both in vivo [13, 14] a nd in vitro [15, 16] situations, TPA causes the release from phospholip id pools and subseq ue nt m eta bolism of AA. (2) TPAinduced ea r ede ma can be inhibited 01' at least modified by age nts whose presumed mechanis m of action is inhibition of AA metabolism [7, 8] .
The demonstration that topicall y a pplied AA indu ced a n even, more a brupt a nd short-lived edema followed by a specifi c unresponsive ness to both AA a nd TPA provides strong support for the rol e of AA metabolites in these phe nomena. Even t hough relatively high doses of AA were used in t his study, histo logic a nd gross observations exclude nonspecific toxi city effects. While the participation of other inflammation mediators cannot be excl uded at. this tim e, recent observations conce rning t he actions of various a rachidonate me tabolites provide t he basis for a tentative expl1;l natio n of ou r results.
In t he ear reaction to TPA, vasodilatation is apparent within 1-2 hI' a nd lasts for as long as 48 hr. This is consistent with an early [13] and prolonged [14] production of vasodilatory prostaglandins, as s hown for mouse dorsal s kin after TPA treatment.
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Th e increase in erythe ma in response to reapplication of TP A or AA is consistent with stimulation of prostaglandin production to even greater leve ls. Prostaglandins (and PGU do not by themselves cause edema, but by increas ing blood now they enhance the effects of' agents causing vascula r perm ea bility such as complement-derived products, bradykinin [17) and the leukotrienes [18, 19] . The tachyphylactic effects which we have described are related to vascular permeab ili ty changes and not to vasodilatation or blood now changes. Further studies are needed to determine whi ch mediators of vascular permeabili ty are involved in the TPA-and AA-induced ear edemas and whether the effects observed are the result of mediator depletion or a true tachyph y laxis. In view of the inhibitory effects of phenidone and nordihydroguaiaretic acid on both inflammations (Table II) , we are proceeding on the assumption t hat lipoxygenase products are respons ible for inducing vascular leakage in these instances.
